Archive
30 stories in PREVENTATIVE HEALTH & LONGEVITY
Forgetting a dose or fearing a double dose is common. Here is what 2025-2026 guidance says to do in the moment, calmly and safely.
Statins spark fierce debate online. Here is what 2025-2026 evidence says about real risks, real benefits, and who should take them.
New data shows a 35% increase in Vitamin K deficiency bleeding among infants whose parents decline the shot. Learn why this protection is essential.
In 2025, 23,000 never-smokers were diagnosed with lung cancer in the U.S. Learn the environmental, genetic, and biological factors behind this rising trend.
Yale scientists found a hidden retinal network that regulates light adaptation, affecting over 2.2 billion people with vision issues worldwide (WHO, 2024). Learn its impact on eye health.
GLP-1 receptor agonists treat diabetes, obesity, and cardiovascular risk. We break down how semaglutide and tirzepatide work, who benefits, what they cost, and what the 2026 evidence shows about muscle loss.
Longevity science spent decades on male data. In 2026 the focus finally turns to women's biology, ovarian aging, and healthspan.
Non-adherence is a 300 billion dollar crisis with real harm. Practical, pharmacist-backed ways to take medications as prescribed.
PGx testing is moving mainstream. How a genotype report becomes an actionable counseling moment at the pharmacy.
